Hemagen Diagnostics, Inc.
HMGN · OTC
9/30/2012 | 9/30/2011 | 9/30/2010 | 9/30/2009 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$907 | -$880 | -$156 | -$808 |
| Dep. & Amort. | $164 | $186 | $164 | $157 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $48 | $47 | $42 | $53 |
| Change in WC | $288 | $270 | -$197 | $327 |
| Other Non-Cash | $49 | $40 | -$36 | $288 |
| Operating Cash Flow | -$359 | -$337 | -$183 | $17 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$91 | -$56 | -$74 | -$115 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $35 | $210 | $210 | $0 |
| Other Inv. Act. | $35 | $3 | $41 | $262 |
| Investing Cash Flow | -$56 | $156 | $177 | $147 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $307 | $271 | -$31 | -$223 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $307 | $271 | -$31 | -$223 |
| Forex Effect | -$40 | -$29 | $33 | $117 |
| Net Chg. in Cash | -$147 | $62 | -$5 | $58 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $214 | $152 | $156 | $99 |
| End Cash | $66 | $214 | $152 | $156 |
| Free Cash Flow | -$450 | -$394 | -$257 | -$98 |